|
Audience |
Technical Skills
|
Ethical/Social/Professional Skills |
|
Minimum for all audiences
|
-
Identify
and define Terminology
-
Describe basics of economic
evaluation: principles
-
Evaluation grid: when is an
economic evaluation necessary
-
Explain the techniques of
basic statistics
-
Distinguish between clinical
and statistical significance
-
Evaluate the quality of a
publication/report
-
Describe methods for
literature searches and reviews
-
Identify the basics of QOL/PROs
|
-
Explain
basics of regulatory/reimbursement issues in own country
-
Describe one’s own health care
system
- Identify and
describe the different possible perspectives of health economic
evaluations
-
Explain the consequences of
separate budgets for pharmacy, hospitals etc…
|
|
Pharmaceutical Industry
Marketing & Sales; Managers, etc |
-
Explain the basics of economic
evaluation: principles and methods
-
Compare and
contrast QOL/PRO and Utilities; between costs and charges
-
Explain decision
tree-calculations and terminology
-
-
|
-
Describe
regulatory issues in outcomes research marketing
-
Explain the
function of outcomes research within an
organization/understanding organization politics
-
Explain the
role of health economic evaluations within a multi-factorial
decision making process
-
Describe the
ethical use of economic evaluation and outcomes research in the
marketing of pharmaceuticals
-
Describe
strategic planning of economic evaluation studies in clinical
trial phases
|
|
Formulary Committee Members
responsible for drug
evaluations |
-
Explain the basics of economic
evaluation: principles and methods
-
Identify and describe basic
epidemiology
-
Explain budget impact models
|
|
|
Clinicians |
|
- Define and
describe the basics of rationing health care (Example:
understanding of concrete examples of rationing)
|
|
Pharmacoeconomics & Outcomes
Researchers |
-
Explain the basics of economic
evaluation: principles and methods
-
Explain decision
tree-calculations and terminology
-
Describe Markov chain an alysis
and calculation
-
List and
explain data collection methods (expert panel, chart
abstraction, database research)
|
-
Identify and
explain implications of rationing based on benchmarks/league
tables
-
Interpret outcome studies at the
population level
-
Interpret within a clinical
context
-
List and explain ethical issues
around resource allocation
-
Describe political aspects of
functioning within an organization
-
Explain the healthcare policy
process
|
|
Health Policy-makers/funders |
|
|
|
Audience |
Technical
Skills
|
Ethical/Social/Professional
Skills |
|
Minimum for all audiences
|
|
|
|
Pharmaceutical Industry Marketing & Sales; Managers, etc |
-
Ability to adapt a study to an
alternate setting
-
Interpret the
results of a study in the overall context of a products value
-
Choose and
use appropriate instruments to interpret economic data correctly
|
-
Prepare and present an unbiased
presentation of a study
-
Identify regulatory issues
-
Identify ethical considerations
in study designs
-
Identify the strength and
weakness of certain economic approaches
-
Explain financial and service
flow in the health system
-
Address economic results to the
right group(s)/person(s)
|
|
Formulary Committee Members
responsible for drug
evaluations |
-
Interpret the
results of an evaluation in terms of internal and external
validity
-
Critically evaluate a study
-
Make findings
of a study generalizable to other populations through designing
a study or providing access to data
-
Prepare a summary report of
findings
|
|
|
Clinicians |
-
Critically (and correctly)
evaluate a study
-
Possess an understanding of
sources of bias in OR studies
-
Interpret decision
tree-calculations and terminology
-
Describe Markov chain analysis
and calculation
|
|
|
Pharmacoeconomics & Outcomes
Researchers |
-
Design,
implement and analyze a study and to adapt an evaluation to a
specific setting
-
Act as a co-author or sole
author on a manuscript
-
Develop,
design, and carryout pharmacoeconomic and outcome studies
-
Develop
decision trees (modeling studies including Monte Carlo
simulation, Markov modeling, sensitivity analysis)
-
-
Critique
internal and external validity of research designs and measuring
instruments
-
Design and implement budget
impact analysis
-
Conduct probabilistic
sensitivity analysis
-
Conduct survival analyses
|
-
Evaluate issues for more than
one reimbursement setting
-
Coordinate pharmacoeconomic and
outcome studies
-
Identify and evaluate ethical
issues on a global basis
-
Compare &
contrast different approaches to the distribution of resources
(e.g., utilitarianism, Rawlsian, etc.)
-
Address economic results to the
right group(s)/person(s)
|
|
Health Policy-makers/funders |
-
Critically evaluate a study
-
Interpret the results of a
budget impact analysis
-
Challenge clinical and economic
data assumptions
|
-
Interpret outcome
studies at the population level
-
Interpret study results within a
clinical context
-
Address ethical issues
concerning resource allocation and priority setting
-
Identify strengths and
weaknesses of different economic approaches
- Differentiate between allocative and technical efficiency goals
from a policy perspective
|
|
Audience |
Technical Skills
|
Ethical/Social/Professional
Skills |
|
Minimum for
all audiences |
|
|
|
Pharmaceutical Industry
Marketing & Sales; Managers, etc |
-
Interpret
findings so they are applicable to a specific population
-
Translate
findings into alternative policy proposals
-
Suggest alternative approaches
to a given pharmacoeconomic problem
|
-
Identify
and explain regulatory issues in different countries
-
Develop
internal standards
-
Lead a
roundtable or act as an internal expert in OR
|
|
Formulary
Committee Members
responsible for drug evaluations |
-
Calculate the specific budget
impact, in terms of total costs, of the introduction of a new
agent to a new formulary
-
Evaluate and verify the quality
of a probabilistic sensitivity analysis
|
|
|
Clinicians |
-
Ability to design a valid and
relevant study for use in medical decision making
-
Conceive/apply
state-of-the-art methods
-
-
Differentiate between generic and specific QOL instrument
|
|
|
Pharmaco-economics & Outcomes Researchers |
|
|
|
Health
Policy-makers/funders |
|
|